iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
Last trade$1.55
Day change-$0.335 (-17.82%)
Day range$1.50 – $2.02
Volume124,714
Market cap$14M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for ITOC.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for ITOC.
Recent news
Company coverage with links to the original publishers.
A class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) alleging that the company made materially false and misleading statements regarding market manipulation schemes, fraudulent trading activity, and stock price inflation. The lawsuit covers investors who purchased shares between September 5, 2024 and July 29, 2025. The lead plaintiff deadline is September 29, 2026.
The Portnoy Law Firm has filed a class action lawsuit on behalf of iTonic Holdings investors who purchased securities between September 5, 2024 and July 29, 2025. The complaint alleges that company officers, directors, auditor Marcum Asia CPAs LLP, and IPO underwriters orchestrated a pump-and-dump scheme involving fraudulent promoters impersonating financial advisors. The scheme allegedly collapsed on July 29, 2025, when iTonic's stock price plummeted approximately 95% in a single trading session.
A class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) for allegedly failing to disclose a market manipulation and fraudulent promotion scheme involving social media misinformation. The complaint claims the company's securities were subject to extreme price volatility and trading halts due to the manipulation scheme, and that positive statements about the company lacked reasonable basis. Investors who purchased PTHL securities between September 5, 2024, and July 29, 2025, have until September 28, 2026, to apply as lead plaintiff.
A class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) alleging that the company made materially false statements and failed to disclose a market manipulation scheme involving social media misinformation and fraudulent trading activity. The lawsuit covers investors who purchased shares between September 5, 2024 and July 29, 2025. The lead plaintiff deadline is September 29, 2026.
A class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) alleging that the company made materially false and misleading statements regarding market manipulation schemes, fraudulent trading activity, and stock price inflation. The lawsuit covers investors who purchased shares between September 5, 2024 and July 29, 2025. The lead plaintiff deadline is September 29, 2026.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.